Cargando…

Driving forces in amyloidosis: How does a light chain make a heavy heart?

Light-chain amyloidosis (AL) is a fatal disorder wherein the immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the light chain variable domain (V(L)) are tightly linked to amyloidosis, but how these mutations drive AL is u...

Descripción completa

Detalles Bibliográficos
Autor principal: Otzen, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191319/
https://www.ncbi.nlm.nih.gov/pubmed/34019874
http://dx.doi.org/10.1016/j.jbc.2021.100785
_version_ 1783705855167823872
author Otzen, Daniel E.
author_facet Otzen, Daniel E.
author_sort Otzen, Daniel E.
collection PubMed
description Light-chain amyloidosis (AL) is a fatal disorder wherein the immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the light chain variable domain (V(L)) are tightly linked to amyloidosis, but how these mutations drive AL is unknown. In recent work, Rottenaicher et al. analyze five mutations found in the V(L) of a patient with cardiac AL. Their data suggest that decreased V(L) stability and increased flexibility in the core of the V(L), caused by mutations outside of this core, could be key to aggregation and highlight the delicate balancing act required for antibody maturation to enable antigen recognition while not altering protein biophysics.
format Online
Article
Text
id pubmed-8191319
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-81913192021-06-16 Driving forces in amyloidosis: How does a light chain make a heavy heart? Otzen, Daniel E. J Biol Chem Editors' Pick Highlight Light-chain amyloidosis (AL) is a fatal disorder wherein the immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the light chain variable domain (V(L)) are tightly linked to amyloidosis, but how these mutations drive AL is unknown. In recent work, Rottenaicher et al. analyze five mutations found in the V(L) of a patient with cardiac AL. Their data suggest that decreased V(L) stability and increased flexibility in the core of the V(L), caused by mutations outside of this core, could be key to aggregation and highlight the delicate balancing act required for antibody maturation to enable antigen recognition while not altering protein biophysics. American Society for Biochemistry and Molecular Biology 2021-05-18 /pmc/articles/PMC8191319/ /pubmed/34019874 http://dx.doi.org/10.1016/j.jbc.2021.100785 Text en © 2021 The Author https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editors' Pick Highlight
Otzen, Daniel E.
Driving forces in amyloidosis: How does a light chain make a heavy heart?
title Driving forces in amyloidosis: How does a light chain make a heavy heart?
title_full Driving forces in amyloidosis: How does a light chain make a heavy heart?
title_fullStr Driving forces in amyloidosis: How does a light chain make a heavy heart?
title_full_unstemmed Driving forces in amyloidosis: How does a light chain make a heavy heart?
title_short Driving forces in amyloidosis: How does a light chain make a heavy heart?
title_sort driving forces in amyloidosis: how does a light chain make a heavy heart?
topic Editors' Pick Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191319/
https://www.ncbi.nlm.nih.gov/pubmed/34019874
http://dx.doi.org/10.1016/j.jbc.2021.100785
work_keys_str_mv AT otzendaniele drivingforcesinamyloidosishowdoesalightchainmakeaheavyheart